News
Biotech company Alnylam Pharmaceuticals conceded defeat for now in a lawsuit against Pfizer and BioNTech over technology in ...
The European Court of Justice Wednesday ruled there was no plausible reason to block the New York Times from getting European ...
1d
MedPage Today on MSNPfizer Confirms: Leading JAK Inhibitor Often Comes With Weight GainAfter 6 months, placebo was associated with a mean weight gain of 0.4 kg (o.88 lb), compared with 1.2-1.9 kg (2.6-4.2 lb) ...
Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...
Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these ...
A case against one of the major COVID-19 vaccine providers filed by the Kansas Attorney General will be heard at the state ...
Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...
The EU’s general court has dismissed the European Commission’s refusal to disclose text messages its president Ursula von der ...
European Court of Justice found that the Commission failed to explain why text messages with Pfizer should be kept from the ...
European Commission President Ursula von der Leyen lost a court fight against attempts to force her to disclose secret text ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results